Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by scarlet1967on Jan 30, 2021 9:31am
150 Views
Post# 32427835

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18To be decent/humble is a rare commodity which actually helps running a business, it createy trust among your customers but being stubborn and stuck to old values is an epic failure.
How many times Wino said he was standed corrected and I applaud that character cause acceptance of being wrong is hard  for most of us even Jiim said he was wrong/greedy not selling at $14. I was also greedy not selling and wrong having said that all of us who went through the roller coaster history of TH shouldn't be judged as idiots cause while the Egrifta's sales came short Trogarzo came around and while Trogarzo's sales didn't materialize HIV NASH came around and then more encouraging news from Sort1 and General NASH so as a somewhat biased shareholders we stayed put.
My point is days of knocking doors are long gone because of powerful social media platforms, Twitter followers are selling artificially to businesses to make them more legitimate, we now have influential YouTube celebrities, the powerful retail investors are bringing big hedge funds to their knees as we are seeing they evidently cumulatively (the small mom and dad investors) are battling the big shorted funds in the US.
This is the new normality thanks to ongoing evolution of technology which enable rapid flow of information.
So why the company doesn't take advantage of it and staying behind others who are not stubborn and have realized their old strategies in a new environment wouldn't work and made necessary adjustments moving in right direction.
The powerful retail marketing has been successful with a proven track record and THTX needs to adapt to the reality of the situation.

<< Previous
Bullboard Posts
Next >>